RFK Jr. and the FDA: A Post-Regulatory Landscape?
The Core of the Critique On the coronary heart of RFK Jr.’s critique lies a elementary mistrust of the FDA and its interactions with the pharmaceutical trade. He argues that the company is riddled with conflicts of curiosity, usually prioritizing the monetary features of drug firms over the well being and well-being of the general … Read more
